人参稀有皂苷Compound K混合胶束的处方优化及体外评价
x
请在关注微信后,向客服人员索取文件
篇名: | 人参稀有皂苷Compound K混合胶束的处方优化及体外评价 |
TITLE: | |
摘要: | 目的:优化人参稀有皂苷Compound K(CK)混合胶束的处方,考察其体外释放度和表观渗透系数(Papp)。方法:以大豆磷脂和维生素E聚乙二醇1000琥珀酸酯(TPGS)为辅料,采用溶剂挥发法制备CK混合胶束。以载药量、包封率、粒径为指标,采用正交试验优化投药量、大豆磷脂-TPGS比例、水化体积。考察最优处方所制胶束的形态、粒径、载药量、包封率、溶解度、体外释放度和在结肠腺癌Caco-2细胞模型中的Papp。结果:CK混合胶束的最优处方投药量为1.0 mg,大豆磷脂-TPGS比例为1 ∶ 1,水化体积为10 ml。所制混合胶束呈球形或类球形,平均粒径为(110±2.69) nm,载药量为(4.32±0.19)%,包封率为(92.23±2.76)%,溶解度为(469.21±0.024) μg/ml,150 h时累积释放度为(66.19±0.027)%(n=3)。CK原料药和CK混合胶束的Papp分别为26.20、3.78(n=6)。结论:优化的制备工艺可行,成功制得CK混合胶束。 |
ABSTRACT: | OBJECTIVE: To optimize the formulation of rare ginsenoside Compound K (CK) mixed micelle, and to investigate its in vitro release and apparent permeability coefficients (Papp). METHODS: Using soy lecithin and vitamin E polyethylene glycol 1 000 succinate (TPGS) as excipients, CK mixed micelle was prepared by solvent evaporation method. Using drug-loading amount, encapsulation efficiency and particle size as index, orthogonal test was adopted to optimize feeding amount, the ratio of granulesten to TPGS and hydration volume; the micelle prepared by optimal formulation was investigated in respects of form, particle size, drug-loading amount, encapsulation efficiency, solubility, in vitro release; Papp of colon adenocarcinoma Caco-2 cell model was also inspected. RESULTS: The optimal formulation was as follows as feeding amount 1.0 mg, the ratio of granulesten to TPGS 1 ∶ 1, hydration volume 10 ml. The mixed micelles were spherical or spheroidal; the average particle size was (110±2.69) nm, and drug-loading amount was (4.32±0.19)%, entrapment efficiency was (92.23±2.76)%, and average solubility was (469.21±0.024) μg/ml; 150 h accumulative release rate was (66.19±0.027)% (n=3). Papp of CK crude drug and CK mixed micelle were 26.20 and 3.78 (n=6). CONCLUSIONS: The optimized preparation technology is feasible, and CK mixed micelle is prepared successfully. |
期刊: | 2016年第27卷第28期 |
作者: | 钱薇,于兆慧,朱云泽 |
AUTHORS: | QIAN Wei,YU Zhaohui,ZHU Yunze |
关键字: | 人参稀有皂苷Compound K;混合胶束;正交试验;处方优化;结肠腺癌Caco-2细胞 |
KEYWORDS: | Rare ginsenoside Compound K; Mixed micelles; Orthogonal test; Formulation optimization; Colon adenocarcinoma Caco-2 cell |
阅读数: | 447 次 |
本月下载数: | 3 次 |
* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!